BEMED.

Study name	'Medical treatment of Meniere's disease with betahistine: a placebo‐controlled, dose‐finding study'
Methods	Placebo‐controlled, double‐blind, randomised controlled trial
Participants	Ménière's disease
Interventions	1. Therapy with high‐dose betahistine (3 x 48 mg) 2. Therapy with low‐dose betahistine (2 x 24 mg) 3. Placebo
Outcomes	Number of vertigo attacks Median duration of vertigo attacks and median severity of vertigo attacks
Starting date	2007
Contact information	Prof M Strupp Klinikum Grosshadern Abt. f. Neurologie Marchioninistrasse 15
Notes	Recruitment completed. Data reportedly in analysis (Prof M Strupp, personal communication).